Industry & Business

Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award

 Breaking News
  • Sisk Reports Strong Performance For 2018 Sicon Limited, which is the holding company for Sisk’s construction and construction related activities in Ireland, the United Kingdom and a number of international markets, has reported a 24% increase in turnover to just under €1.2 billion and a pre-tax profit of €28.3 million for the year ended 31 December 2018. Over 97% of the [...]...
  • Ireland’s Most Energy Efficient Residential and Commercial Building Projects Honoured at 2019 ISOVER Awards Simply Architecture, and their new build residential project – ‘The Fairways’ in Cork – has been named the winner of the 2019 Overall ISOVER Award, as well as Designer of the Year 2019, at the third ISOVER Awards. The awards ceremony, which took place recently at the Smock Alley Theatre in Dublin, saw over 100 [...]...
  • Premium Products and Value Prices a Hit With Grocery Shoppers The latest figures from Kantar show that overall the Irish grocery market grew by 4.2% over the 12 weeks to 19 May 2019, with Dunnes Stores holding off the challenge of Tesco and retaining pole position. Respective growth of 12.6% and 5.9% for Aldi and Lidl means that the retailers’ combined grocery market share stands [...]...
  • Strencom Acquires Leading Irish Security Company Baker Security & Networks Strencom, the Irish managed connectivity and cloud computing provider, has acquired managed network and cybersecurity company, Baker Security & Networks. The deal will bolster Strencom’s security and networking offering and further the company’s ambition to achieve annual recurring revenue of €50 million. Established in 2000, Strencom provides managed connectivity, unified communications and managed cloud hosting services to [...]...
  • New Report on Customer Experience Sector in Ireland IDA Ireland has launched a new report detailing the extent to which 5,000 jobs in the Customer Experience (Cx) sector in Ireland will be affected by technological and generational forces over the coming years. The document sets out a vision for Irish operators in the Cx sector that urges them to remain competitive by focusing [...]...

Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award

Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award
December 10
14:54 2018

The NovaUCD 2018 Innovation Award has been presented to University College Dublin’s (UCD) Professor Stephen Pennington (pictured), a global leader in proteomics (the study of proteins) research and innovation. The Award was presented to him in recognition of his commitment and success in protein biomarker research, undertaken during the last 15-years at the UCD School of Medicine, and previously in the UK, and the conversion of this research into diagnostic tests for clinical use which can have a positive impact on the lives of patients worldwide.

Professor Pennington is the founder and Chief Scientific Officer of Atturos, a UCD spin-out company, which is developing a portfolio of novel multi-marker blood tests. Atturos’ first test, OCProDx, is a prostate cancer test which will help some men avoid unnecessary over treatment of their cancer. The company is planning to launch this test onto the market in 2020.

Every year over 1.2 million men globally receive a diagnosis of prostate cancer and the aim of Atturos’ test is to determine whether or not the cancer remains in the prostate or has spread beyond it. With this information, patients can make a more informed decision about their treatment, including the opportunity of monitoring the disease via active surveillance.

Professor Pennington is also the incoming President of the Human Proteome Organisation (HUPO), the international scientific organisation of over 1000 members representing and promoting proteomics, which is headquartered in Vancouver, Canada. He is the first researcher from an Irish University to be elected to this prestigious position.

Professor Andrew J. Deeks, UCD President, said: “The Award recognises the quality and impact of his peer-reviewed research, over many years, and his commitment and continuing enthusiasm to convert the outputs of his protein biomarker research into diagnostic tests for clinical use. Atturos, the company established by Professor Pennington, is currently developing a blood test to help men diagnosed with prostate cancer make more informed decisions about their treatment. This test can have significant benefit to patients worldwide and I wish him and the Atturos team every success with the launch of this test onto the global market.”

He added: “This Award also recognises Steve as an innovation and entrepreneurial leader who combines excellence in teaching and research with a proven commitment to translating his research outcomes into commercial applications to impact the lives of people.”

Before moving to UCD in 2003 Professor Pennington was a Wellcome Trust lecturer at the University of Liverpool. There he became deeply involved in a new field of biochemistry research, now called proteomics, and co-authored the first review of this newly emerging field. While at Liverpool he also developed strong links with industry partners such as AB Sciex and Waters and was actively involved in technology licensing.

On moving to Ireland Professor Pennington helped to establish the University’s proteomics facility at the UCD Conway Institute. During the last 15-years he has been active in the implementation of collaborative proteomics projects, in particular clinical translational projects that align significant clinical needs to basic research.

In recent years this has been focused on the discovery and subsequent quantitative measurement of protein biomarker signatures, the latter using targeted proteomics strategies. It is this experience and expertise that lead to the establishment of Atturos.

On receiving the NovaUCD 2018 Innovation Award, Professor Stephen Pennington, said: “It is a great honour to receive this prestigious Award and to follow in the footsteps of previous awardees. This Award reflects the valued guidance and input of many colleagues and collaborators over many years and the ‘can do’ attitude instilled in me by two remarkable ladies, my mother and grandmother. It also reflects the recent invaluable mentorship of Mike Feeney formerly of the IDA and Enterprise Ireland.”

He added: “I am very excited about the potential of Atturos to make a significant impact in the new era of personalised medicine initially by helping men diagnosed prostate cancer make the life changing decisions they face. I would like to take this opportunity to acknowledge the huge support of Enterprise Ireland, NovaUCD, Agilent Technologies and MSC, amongst others, who have supported me and the Atturos team on our journey to date.”

He concluded: “The Award also recognises the significant support and commitment of a large number of research colleagues, as well as current and past research students, who have worked closely with me over many years to help to develop our contribution to the proteomics research and innovation ecosystem at UCD, in Ireland and internationally.”

Professor Pennington is a named inventor on 4 priority patent filings and has also published over 90 scientific papers, edited and contributed to several books including editing one of the first books on proteomics that was translated into Chinese and Japanese. He is on the editorial board of several journals and regularly reviews manuscripts and grants for a number of organisations.

On an international level Professor Pennington has been the President of the British Society for Proteome Research since 2016 and in 2017 he was the lead organiser of the 16th Annual World Congress of the Human Proteome Organisation, held in the Convention Centre in Dublin. This Congress attracted 1500 delegates and included a gala dinner, in the Royal College of Physicians, at which former Vice-President Joe Biden was the guest of honour.

The NovaUCD Innovation Award was established in 2004 to highlight University College Dublin’s commitment to innovation. The Award is presented annually to an individual, company or organisation or group in recognition of excellence in innovation or of success achieved in the commercialisation of UCD research or other intellectual activity.

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements





















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4